HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Outcomes of liver resection for hepatocellular carcinoma in liver transplantation era.

AbstractAIMS:
Surgical treatment for early-stage hepatocellular carcinoma (HCC) is toward transplantation. However, liver resection remains the major surgical treatment for HCC in Asia. This study is to examine the results of liver resection when liver transplantation became an option of treatment for early-stage HCC.
METHODS:
In this retrospective cohort study, 1639 patients with resectable HCC were reviewed and divided into two groups. In the 1st period (2002-2005), all 679 patients received liver resection. In the 2nd period (2006-2010), 916 patients had liver resection and 44 patients jointed liver transplantation program. The results of treatment in these two periods were analyzed.
RESULTS:
The characteristics of tumors were the most important factors of tumor recurrence after liver resection. Liver function reserve, characteristics of tumors, and surgeons' endeavor were all independent factors for overall survival after liver resection. When the patients with oligo-nodular tumors or portal hypertension with low platelet count had liver transplantation rather than liver resection in the 2nd period, the survival rates in the 2nd period were improved. When the patients in the 1st period with low platelet count (≤105 × 10(3)/uL) were subtracted, the 5-year survival rate of the patients with one-segmentectomy for small-sized HCC in the 1st period was similar to those in the 2nd period and transplant patients.
CONCLUSIONS:
The outcomes of liver resection were improved while liver transplantation was performed for the patients with suspicious portal hypertension. Platelet count, 105 × 10(3)/uL, could be a watershed for early stage HCC patients to undergo liver resection or liver transplantation.
AuthorsW-C Lee, C-F Lee, C-H Cheng, T-J Wu, H-S Chou, T-H Wu, R-S Soong, K-M Chan, M-C Yu, M-F Chen
JournalEuropean journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology (Eur J Surg Oncol) Vol. 41 Issue 9 Pg. 1144-52 (Sep 2015) ISSN: 1532-2157 [Electronic] England
PMID26163047 (Publication Type: Journal Article)
CopyrightCopyright © 2015. Published by Elsevier Ltd.
Topics
  • Aged
  • Carcinoma, Hepatocellular (complications, surgery)
  • Cohort Studies
  • Disease-Free Survival
  • Female
  • Hepatectomy
  • Hospital Mortality
  • Humans
  • Hypertension, Portal (complications, surgery)
  • Liver Neoplasms (complications, surgery)
  • Liver Transplantation
  • Male
  • Middle Aged
  • Neoplasm Recurrence, Local
  • Proportional Hazards Models
  • Retrospective Studies
  • Taiwan
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: